These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27567243)

  • 1. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial.
    Sheth KN; Elm JJ; Molyneaux BJ; Hinson H; Beslow LA; Sze GK; Ostwaldt AC; Del Zoppo GJ; Simard JM; Jacobson S; Kimberly WT
    Lancet Neurol; 2016 Oct; 15(11):1160-9. PubMed ID: 27567243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design.
    Sheth KN; Elm JJ; Beslow LA; Sze GK; Kimberly WT
    Neurocrit Care; 2016 Feb; 24(1):132-9. PubMed ID: 26268138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
    Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
    Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotherapy for malignant cerebral edema in a phase 2 prospective, double blind, randomized, placebo-controlled study of IV glibenclamide.
    Hinson HE; Sun E; Molyneaux BJ; von Kummer R; Demchuk A; Romero J; Taylor Kimberly W; Sheth KN
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104916. PubMed ID: 32414580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analysis of glyburide as a novel therapy for preventing brain swelling.
    Sheth KN; Kimberly WT; Elm JJ; Kent TA; Yoo AJ; Thomalla G; Campbell B; Donnan GA; Davis SM; Albers GW; Jacobson S; del Zoppo G; Simard JM; Stern BJ; Mandava P
    Neurocrit Care; 2014 Aug; 21(1):43-51. PubMed ID: 24671831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
    King ZA; Sheth KN; Kimberly WT; Simard JM
    Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor Outcomes Related to Anterior Extension of Large Hemispheric Infarction: Topographic Analysis of GAMES-RP Trial MRI Scans.
    Payabvash S; Falcone GJ; Sze GK; Jain A; Beslow LA; Petersen NH; Sheth KN; Kimberly WT
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104488. PubMed ID: 31787498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction.
    Vorasayan P; Bevers MB; Beslow LA; Sze G; Molyneaux BJ; Hinson HE; Simard JM; von Kummer R; Sheth KN; Kimberly WT
    Stroke; 2019 Nov; 50(11):3021-3027. PubMed ID: 31537189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
    Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
    Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
    Chamorro A; Amaro S; Castellanos M; Segura T; Arenillas J; Martí-Fábregas J; Gállego J; Krupinski J; Gomis M; Cánovas D; Carné X; Deulofeu R; Román LS; Oleaga L; Torres F; Planas AM;
    Lancet Neurol; 2014 May; 13(5):453-60. PubMed ID: 24703208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide is associated with attenuated vasogenic edema in stroke patients.
    Kimberly WT; Battey TW; Pham L; Wu O; Yoo AJ; Furie KL; Singhal AB; Elm JJ; Stern BJ; Sheth KN
    Neurocrit Care; 2014 Apr; 20(2):193-201. PubMed ID: 24072459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of intravenous glyburide in patients with a large ischemic stroke.
    Sheth KN; Kimberly WT; Elm JJ; Kent TA; Mandava P; Yoo AJ; Thomalla G; Campbell B; Donnan GA; Davis SM; Albers GW; Jacobson S; Simard JM; Stern BJ
    Stroke; 2014 Jan; 45(1):281-3. PubMed ID: 24193798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D; Faivre S; Mesía R; Remenár É; Li SH; Karpenko A; Dechaphunkul A; Ochsenreither S; Kiss LA; Lin JC; Nagarkar R; Tamás L; Kim SB; Erfán J; Alyasova A; Kasper S; Barone C; Turri S; Chakravartty A; Chol M; Aimone P; Hirawat S; Licitra L
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.
    Hill MD; Goyal M; Menon BK; Nogueira RG; McTaggart RA; Demchuk AM; Poppe AY; Buck BH; Field TS; Dowlatshahi D; van Adel BA; Swartz RH; Shah RA; Sauvageau E; Zerna C; Ospel JM; Joshi M; Almekhlafi MA; Ryckborst KJ; Lowerison MW; Heard K; Garman D; Haussen D; Cutting SM; Coutts SB; Roy D; Rempel JL; Rohr AC; Iancu D; Sahlas DJ; Yu AYX; Devlin TG; Hanel RA; Puetz V; Silver FL; Campbell BCV; Chapot R; Teitelbaum J; Mandzia JL; Kleinig TJ; Turkel-Parrella D; Heck D; Kelly ME; Bharatha A; Bang OY; Jadhav A; Gupta R; Frei DF; Tarpley JW; McDougall CG; Holmin S; Rha JH; Puri AS; Camden MC; Thomalla G; Choe H; Phillips SJ; Schindler JL; Thornton J; Nagel S; Heo JH; Sohn SI; Psychogios MN; Budzik RF; Starkman S; Martin CO; Burns PA; Murphy S; Lopez GA; English J; Tymianski M;
    Lancet; 2020 Mar; 395(10227):878-887. PubMed ID: 32087818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
    Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD;
    Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.
    Kimberly WT; Bevers MB; von Kummer R; Demchuk AM; Romero JM; Elm JJ; Hinson HE; Molyneaux BJ; Simard JM; Sheth KN
    Neurology; 2018 Dec; 91(23):e2163-e2169. PubMed ID: 30446594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
    Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.